Personalized cancer immunotherapy for aggressive hypoxic tumors with blockbuster potential.

Our Target Mechanism For Treating Hypoxic Tumors: Carbonic Anhydrase IX (CA IX).

Our Mission:
- to fill the gap in treatment of oncology diseases with poor prognosis,
- to increase survival rate and bring hope to patients who have undergone different types of therapies without success,
- to deliver novel therapeutics that match the principle of personalized medicine which will help patients to improve the quality of their lives.

Crunchbase
https://www.crunchbase.com/organization/mabpro-therapeutics

Mabpro Therapeutics

Org chart

Teams

Offices

Mabpro Therapeutics

Org chart

Teams

Offices

Related companies